Ginsenoside Ro attenuates aging-related cognitive impairment and associated neuroinflammatory changes via multi-target modulation of the PI3K-Akt axis: a convergent network pharmacology and experimental validation study
- DOI
- 10.1007/s00210-026-05934-1
- Published
- 2026-09-24
- Container
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00210-026-05934-1,
title = {Ginsenoside Ro attenuates aging-related cognitive impairment and associated neuroinflammatory changes via multi-target modulation of the PI3K-Akt axis: a convergent network pharmacology and experimental validation study},
author = {Jingyi Hou and Kailan Yang and Dandan Zhang and Yi Ba and Yubo Wang and Changqi Zhao and Naiqiang Zhu and Miao Gu},
year = {2026},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
doi = {10.1007/s00210-026-05934-1},
url = {https://doi.org/10.1007/s00210-026-05934-1}
}RIS
TY - JOUR TI - Ginsenoside Ro attenuates aging-related cognitive impairment and associated neuroinflammatory changes via multi-target modulation of the PI3K-Akt axis: a convergent network pharmacology and experimental validation study AU - Jingyi Hou AU - Kailan Yang AU - Dandan Zhang AU - Yi Ba AU - Yubo Wang AU - Changqi Zhao AU - Naiqiang Zhu AU - Miao Gu PY - 2026 JO - Naunyn-Schmiedeberg's Archives of Pharmacology DO - 10.1007/s00210-026-05934-1 UR - https://doi.org/10.1007/s00210-026-05934-1 ER -
APA
Hou, J., Yang, K., Zhang, D., Ba, Y., Wang, Y., Zhao, C., Zhu, N., & Gu, M. (2026). Ginsenoside Ro attenuates aging-related cognitive impairment and associated neuroinflammatory changes via multi-target modulation of the PI3K-Akt axis: a convergent network pharmacology and experimental validation study. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05934-1
Source records
- crossref · retrieved 2026-09-25T04:44:03.623Z